Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes
Agreement forged to develop prefilled cartridges for external insulin pumps
December 23rd, 2004
The Diabetes business unit of Medtronic, Inc., (NYSE: MDT) and Novo Nordisk (NYSE: NVO) announced an agreement to develop the first prefilled cartridges designed for use with Paradigm external insulin pumps. The two companies also agreed to conduct clinical studies and expand medical education highlighting the benefits of maintaining good blood glucose (sugar) control in people with diabetes who use U-100 NovoLog (insulin aspart [rDNA origin] injection) and Paradigm pump therapy. Prefilled cartridges containing NovoLog are expected to offer a convenient option for people using Paradigm pump therapy. Currently, pump users must transfer insulin every 2...
Source: Women's Health Weekly (2004-12-23)
|
